Novel Angiogenic Model Based on Stable, Fluorecently Labled Cell Lines Amenable to High Content Screening
Natalie Prigozhina, Sanford-Burnham Medical Research Institute, speaking at Cell Culture 2012
Recording Signal Transduction Dynamics With Unprecedented Temporal Resolution
Dr Jonathan West, Miniaturisation Group at ISAS, speaking at Single Cell Analysis Europe 2012.
Challenges for Stem Cell Bioprocessing - Scale-Up or Scale-Out?
Christopher Hewitt, Loughborough University, speaking at Cell Culture 2012
Capacitive Immunosensors – A Tool for Detection Where Sensitivity of Conventional ELISA is Not Sufficient
Prof. Bo Mattiasson, Lund University, speaking at Advances in Biodetection and Biosensors 2012.
Companies in Translation with CIRM
Dr Alan Trounson, California Institute for Regenerative Medicine, speaking at Stem Cells 2012
In Vitro, Ex Vivo and in Models to Develop New Therapies for Renal Diseases
Frederick W. K. Tam, Imperial College London, speaking at ADME & Predictive Toxicology Europe 2012
Antibodies and Antibody RNase Fusion Proteins Targeting CD30+ Lymphoma
Thomas Schirrmann PhD, Technische Universitaet Braunschweig, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Glycosylation of IgG antibodies: a Critical Quality Attribute (CQA)
Professor Roy Jefferis, College of Medical and Dental Sciences, University of Birmingham, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Continuous Chromatography (MCSGP) for the Purification of Therapeutic Proteins
Dr Thomas Müller-Späth, ETH Switzerland, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
|<< || 1 2 3 || >>|
|Showing Results 11 - 20 of 28|